Screener
FDIQ vs PBE
Invesco Bloomberg Financial Data Providers ETF vs Invesco Biotechnology & Genome ETF
Key differences
- FDIQ costs 0.23% less per year.
- PBE is significantly larger than FDIQ — larger funds tend to be more liquid and less likely to close.
- FDIQ is classified as fixed income, while PBE is equity — different risk/return profiles.
- Over the last 3 years, FDIQ has delivered higher annualized returns.
- PBE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| FDIQ | PBE | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.58% |
| Fund size (AUM) | $52M | $247M |
| Since | 2011 | 2005 |
| Dividend yield | 2.42% | 1.09% |
| Asset class | fixed income | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +27.5% | +35.8% |
| CAGR 3Y | +22.4% | +10.3% |
| CAGR 5Y | +4.5% | +3.5% |
| Sharpe 3Y | 0.73 | 0.41 |
| Volatility 1Y | 22.13% | 18.63% |
| Max drawdown | -52.86% | -37.84% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to FDIQ and PBE
Explore further